Minneapolis, MN, United States of America

Marco Pravetoni

USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Marco Pravetoni: Innovator in Therapeutic Compositions

Introduction

Marco Pravetoni is a notable inventor based in Minneapolis, MN (US). He has made significant contributions to the field of therapeutic compositions, particularly in the area of immunomodulation. His work focuses on enhancing immune responses to antigens, which has important implications for various medical treatments.

Latest Patents

Marco Pravetoni holds a patent for "Therapeutic compositions and methods with cytokine signaling immunomodulators." This innovative method involves co-administering a composition that includes an antigen and a cytokine signaling immunomodulator to a subject. The applications of this method are diverse, including treating drug abuse, toxicity from drug abuse, infections by pathogens, non-communicable diseases, and increasing antibody production against the antigen. The cytokine-signaling immunomodulator is designed to improve the subject's immune response to the antigen compared to responses without the immunomodulator.

Career Highlights

Marco Pravetoni is affiliated with the Hennepin Healthcare Research Institute, where he continues to advance his research and development in therapeutic methods. His work is characterized by a commitment to improving patient outcomes through innovative medical solutions.

Collaborations

[This section has been skipped due to space constraints.]

Conclusion

Marco Pravetoni's contributions to therapeutic compositions and methods highlight his role as an innovator in the medical field. His patent reflects a significant advancement in immunomodulation, which has the potential to improve treatment strategies for various health conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…